Stella Nyamoya , Felix Schweiger , Markus Kipp , Tanja Hochstrasser
{"title":"铜酮作为髓鞘和轴突损伤的模型","authors":"Stella Nyamoya , Felix Schweiger , Markus Kipp , Tanja Hochstrasser","doi":"10.1016/j.ddmod.2018.09.003","DOIUrl":null,"url":null,"abstract":"<div><p><span>Axonal damage is believed to be the main factor contributing to disease progression<span><span> in multiple sclerosis<span><span> patients. The degeneration of axons could be the result of several different harmful events including inflammation and demyelination. Details of the mechanisms leading to axonal damage are, however, unknown, and distinct preclinical </span>animal models can be used to study mechanisms operant during </span></span>axonal injury<span> development and progression. In this review article, we focus on the cuprizone model, a model for toxic, non-autoimmune-mediated demyelination. We discuss the relevance of this model to investigate demyelination and the </span></span></span>pathophysiology<span> of axonal degeneration. We further discuss the applicability of “cuprizone-combination” models to investigate the intricate interplay of innate and adaptive immune responses during demyelination and axonal degeneration.</span></p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.09.003","citationCount":"6","resultStr":"{\"title\":\"Cuprizone as a model of myelin and axonal damage\",\"authors\":\"Stella Nyamoya , Felix Schweiger , Markus Kipp , Tanja Hochstrasser\",\"doi\":\"10.1016/j.ddmod.2018.09.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Axonal damage is believed to be the main factor contributing to disease progression<span><span> in multiple sclerosis<span><span> patients. The degeneration of axons could be the result of several different harmful events including inflammation and demyelination. Details of the mechanisms leading to axonal damage are, however, unknown, and distinct preclinical </span>animal models can be used to study mechanisms operant during </span></span>axonal injury<span> development and progression. In this review article, we focus on the cuprizone model, a model for toxic, non-autoimmune-mediated demyelination. We discuss the relevance of this model to investigate demyelination and the </span></span></span>pathophysiology<span> of axonal degeneration. We further discuss the applicability of “cuprizone-combination” models to investigate the intricate interplay of innate and adaptive immune responses during demyelination and axonal degeneration.</span></p></div>\",\"PeriodicalId\":39774,\"journal\":{\"name\":\"Drug Discovery Today: Disease Models\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.09.003\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today: Disease Models\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1740675718300240\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675718300240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Axonal damage is believed to be the main factor contributing to disease progression in multiple sclerosis patients. The degeneration of axons could be the result of several different harmful events including inflammation and demyelination. Details of the mechanisms leading to axonal damage are, however, unknown, and distinct preclinical animal models can be used to study mechanisms operant during axonal injury development and progression. In this review article, we focus on the cuprizone model, a model for toxic, non-autoimmune-mediated demyelination. We discuss the relevance of this model to investigate demyelination and the pathophysiology of axonal degeneration. We further discuss the applicability of “cuprizone-combination” models to investigate the intricate interplay of innate and adaptive immune responses during demyelination and axonal degeneration.
期刊介绍：
Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
